GlobeNewswire: Invictus Contains the last 10 of 43 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T01:47:53ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/02/13/1984875/0/en/INVICTUS-GRANTED-CREDITOR-PROTECTION-AND-WILL-COMMENCE-A-STRATEGIC-REVIEW.html?f=22&fvtc=4&fvtv=53241INVICTUS GRANTED CREDITOR PROTECTION AND WILL COMMENCE A STRATEGIC REVIEW2020-02-13T20:55:07Z<![CDATA[Vancouver, B.C., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “Court”) issued an order granting the Company’s application for creditor protection under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). The order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. (“Acreage”), and 2015059 Alberta Ltd. (together with the Company, the “Invictus Group”).]]>https://www.globenewswire.com/news-release/2020/01/03/1966059/0/en/INVICTUS-ANNOUNCES-TERMINATION-OF-THE-PREVIOUSLY-ANNOUNCED-BINDING-LETTER-OF-INTENT-WITH-UNIFIED-CANNABIS-CORP.html?f=22&fvtc=4&fvtv=53241INVICTUS ANNOUNCES TERMINATION OF THE PREVIOUSLY ANNOUNCED BINDING LETTER OF INTENT WITH UNIFIED CANNABIS CORP.2020-01-03T15:46:40Z<![CDATA[Vancouver, B.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to the Company’s news release dated December 16, 2019, the Company has terminated the binding letter of intent with Unified Cannabis Corp. of Calgary, Alberta in respect of the proposed $5.7 million convertible debenture financing.]]>https://www.globenewswire.com/news-release/2019/12/16/1960953/0/en/INVICTUS-ANNOUNCES-5-700-000-CONVERTIBLE-DEBENTURE-FINANCING.html?f=22&fvtc=4&fvtv=53241INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING2019-12-16T13:33:28Z<![CDATA[Vancouver, B.C., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 16, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that it has signed a binding letter of intent dated December 11, 2019 with Unified Cannabis Corp. of Calgary, Alberta (“Unified”) pursuant to which Unified, subject to acceptance by the TSX Venture Exchange (the “Exchange”), has agreed, by way of a non-brokered private placement (the "Private Placement"), to subscribe for secured convertible debentures in the principal amount of $5,700,000 (the "Debentures") with a maturity date of December 31, 2020 (the "Maturity Date") and 29,223,212 common share purchase warrants with an exercise price of $0.19505 per common share of the Company (“Common Share”) and an expiry date of December 21, 2020 (the “Warrants”).]]>https://www.globenewswire.com/news-release/2019/12/13/1960608/0/en/INVICTUS-ANNOUNCES-CHANGE-TO-BOARD.html?f=22&fvtc=4&fvtv=53241INVICTUS ANNOUNCES CHANGE TO BOARD2019-12-13T22:00:00Z<![CDATA[Vancouver, B.C., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 13, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Trevor Dixon has resigned from the Board of Directors of the Company effective immediately. Marc Ripa has been appointed to the Board to fill the casual vacancy.]]>https://www.globenewswire.com/news-release/2019/12/06/1957426/0/en/INVICTUS-ANNOUNCES-RESIGNATIONS.html?f=22&fvtc=4&fvtv=53241INVICTUS ANNOUNCES RESIGNATIONS2019-12-06T17:51:45Z<![CDATA[Vancouver, B.C., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Messrs. Sparkes and Stein have resigned from the Board of Directors of the Company effective December 5, 2019.]]>https://www.globenewswire.com/news-release/2019/12/02/1954988/0/en/INVICTUS-ANNOUNCES-THE-RETURN-OF-TREVOR-DIXON-TO-THE-BOARD-OF-DIRECTORS.html?f=22&fvtc=4&fvtv=53241INVICTUS ANNOUNCES THE RETURN OF TREVOR DIXON TO THE BOARD OF DIRECTORS2019-12-02T17:02:39Z<![CDATA[Vancouver, B.C., Dec. 02, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to the Board of Directors of the Company, his health issues having been resolved, effective today. Mr. Dixon thanks Brenda Dixon for being his alternate Director while he was on medical leave. Ms. Dixon continues her position as a Director and Quality Assurance Person of Acreage Pharms Ltd., a wholly owned subsidiary of the Company.]]>https://www.globenewswire.com/news-release/2019/11/25/1951963/0/en/INVICTUS-CLOSES-TERMINATION-OF-AUTHENTIC-BRANDS-GROUP-LICENSE-AGREEMENT.html?f=22&fvtc=4&fvtv=53241INVICTUS CLOSES TERMINATION OF AUTHENTIC BRANDS GROUP LICENSE AGREEMENT2019-11-25T13:22:47Z<![CDATA[Vancouver, B.C., Nov. 25, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective September 30, 2019, of the previously announced termination of its license agreement with ABG-HMX, LLC pursuant to an omnibus settlement and termination agreement (the “Agreement”). The Company sought and received regulatory approval from the TSX Venture Exchange to complete the termination.]]>https://www.globenewswire.com/news-release/2019/11/05/1941171/0/en/INVICTUS-PROVIDES-UPDATE-ON-ACREAGE-PHARMS-LTD-AND-AB-LABORATORIES-INC.html?f=22&fvtc=4&fvtv=53241INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.2019-11-05T13:27:26Z<![CDATA[Vancouver, B.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) has hired Kris Love as Vice-President of Production effective August 1, 2019. Mr. Love has many years of experience in cannabis production in Canada and already has become an integral asset to the Company’s operation. The fifteen production rooms within Acreage Pharms 40,000 sq. foot facilities have increased cannabis production yields, product quality and cannabinoid profiles while implementing a consistent weekly production schedule. In addition, and under the direction of Invictus’ restructured management team, staffing numbers have been dramatically reduced and production processes have been streamlined to reduce costs and maintain focus on profitability.]]>https://www.globenewswire.com/news-release/2019/10/23/1934539/0/en/INVICTUS-AND-AUTHENTIC-BRANDS-GROUP-MUTUALLY-AGREE-TO-TERMINATE-LICENSE-AGREEMENT.html?f=22&fvtc=4&fvtv=53241INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT2019-10-23T22:30:00Z<![CDATA[Vancouver, B.C., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Vancouver, B.C., October 23, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) The Company and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated June 1, 2018 (the “License Agreement”) pursuant to an omnibus settlement and termination agreement (the “Termination Agreement”). The Company continues to focus on increasing shareholder value by providing quality cannabis and oil to meet the demand of sales to the medical and recreational markets.]]>https://www.globenewswire.com/news-release/2019/10/17/1931292/0/en/INVICTUS-CLOSES-SALE-OF-FUTURE-HARVEST-DEVELOPMENT-LTD.html?f=22&fvtc=4&fvtv=53241INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.2019-10-17T13:00:00Z<![CDATA[Vancouver, B.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective October 16, 2019, of the previously announced sale of all the Company's shares of Future Harvest Development Ltd. ("Future Harvest"), which shares are held by the Company's wholly owned subsidiary Prestige Worldwide Holdings Inc. and comprise 82.5% of Future Harvest's total issued and outstanding shares, to SL 152 Ventures Ltd., a company owned by Mr. Byron Sheppard, a Director, President and CEO of Future Harvest, and whose company holds the remaining 17.5% of Future Harvest (the "Transaction"). The Company sought and received regulatory approval from the TSX Venture Exchange to close the Transaction.]]>